Skip to content
Advertisement

A laboratory worker simulates the workflow in a cleanroom of the BioNTech Corona vaccine production in Marburg, Germany, during a media day on Saturday, March 27, 2021. BioNTech, the Mainz-based company that invented the messenger RNA-based vaccine, is busily ramping up its production capabilities at the company's new production facility in Marburg. BioNTech originally expected the plant could turn out 700 million doses per year; it has since upgraded its expectations to a billion a year. (AP Photo/Michael Probst)

A laboratory worker simulates the workflow in a cleanroom of the BioNTech Corona vaccine production in Marburg, Germany, during a media day on Saturday, March 27, 2021. BioNTech, the Mainz-based company that invented the messenger RNA-based vaccine, is busily ramping up its production capabilities at the company's new production facility in Marburg. BioNTech originally expected the plant could turn out 700 million doses per year; it has since upgraded its expectations to a billion a year. (AP Photo/Michael Probst)

Featured Photo Galleries